A detailed history of Mc Adam, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mc Adam, LLC holds 808 shares of AMGN stock, worth $226,248. This represents 0.01% of its overall portfolio holdings.

Number of Shares
808
Previous 810 0.25%
Holding current value
$226,248
Previous $253,000 2.77%
% of portfolio
0.01%
Previous 0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$309.38 - $337.38 $618 - $674
-2 Reduced 0.25%
808 $260,000
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $15,765 - $19,158
60 Added 8.0%
810 $253,000
Q1 2024

Apr 23, 2024

BUY
$268.87 - $324.56 $7,528 - $9,087
28 Added 3.88%
750 $213,000
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $184,615 - $208,268
722 New
722 $207,000
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $341,117 - $403,365
1,592 New
1,592 $353,000
Q4 2018

Jan 30, 2019

SELL
$178.4 - $208.25 $62,975 - $73,512
-353 Closed
0 $0
Q2 2018

Aug 22, 2018

BUY
$166.05 - $186.51 $5,479 - $6,154
33 Added 10.31%
353 $65,000
Q1 2018

Apr 24, 2018

BUY
$169.43 - $198.0 $54,217 - $63,360
320 New
320 $55,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mc Adam, LLC Portfolio

Follow Mc Adam, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.